{"transactions":[{"id":694237,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":25877,"kind":"person","name":"Zack Debra","position":1,"cik":"0001807743","reported_name":"Zack Debra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-08-06T22:49:22.000Z","date":"2026-08-03","kind":"grant","planned":true,"acquired":true,"shares":324675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as to 25% on August 3, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":324675,"derivative":{"exercise_price":1.54,"expiration_date":"2036-08-03","underlying":"Common Stock","underlying_shares":324675},"source":{"system":"sec-edgar","filing":"0001807743-26-000007","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807743/000180774326000007/ownership.xml","form_type":"4"}},{"id":694236,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":25877,"kind":"person","name":"Zack Debra","position":1,"cik":"0001807743","reported_name":"Zack Debra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-06T22:49:22.000Z","date":"2026-08-03","kind":"grant","planned":true,"acquired":true,"shares":162311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\") granted to Reporting Person under Issuer's 2019 Stock Incentive Plan. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on August 3, 2027, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":162311,"source":{"system":"sec-edgar","filing":"0001807743-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807743/000180774326000007/ownership.xml","form_type":"4"}},{"id":2361162,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":25877,"kind":"person","name":"Zack Debra","position":1,"cik":"0001807743","reported_name":"Zack Debra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-02T21:41:04.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":3241,"price":7.12,"value":23075.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the Reporting Person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted on February 23, 2021."}],"balance_after":84259,"source":{"system":"sec-edgar","filing":"0001274737-22-000019","document":"wf-form4_164625724694463.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807743/000127473722000019/wf-form4_164625724694463.xml","form_type":"4"}},{"id":2408532,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":25877,"kind":"person","name":"Zack Debra","position":1,"cik":"0001807743","reported_name":"Zack Debra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-08T21:23:02.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 50,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of February 4, 2022, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 50,000 shares of restricted stock units granted on February 4, 2022 and 37,500 shares of restricted stock units granted on February 23, 2021."}],"balance_after":87500,"source":{"system":"sec-edgar","filing":"0001274737-22-000011","document":"wf-form4_164435534136243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807743/000127473722000011/wf-form4_164435534136243.xml","form_type":"4"}},{"id":2833080,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":25877,"kind":"person","name":"Zack Debra","position":1,"cik":"0001807743","reported_name":"Zack Debra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option(right to buy)","published_at":"2021-02-25T22:05:08.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is exercisable as it vests. 25% of the shares subject to the option vest on February 23, 2022, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.  In addition, the stock option may become fully vested upon a qualifying termination of employment in connection with a change in control."}],"balance_after":12500,"derivative":{"exercise_price":18.2,"expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001274737-21-000009","document":"wf-form4_161429069393025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807743/000127473721000009/wf-form4_161429069393025.xml","form_type":"4"}},{"id":2833079,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":25877,"kind":"person","name":"Zack Debra","position":1,"cik":"0001807743","reported_name":"Zack Debra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-25T22:05:08.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of March 1, 2020, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 37,500 shares of restricted stock units."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001274737-21-000009","document":"wf-form4_161429069393025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807743/000127473721000009/wf-form4_161429069393025.xml","form_type":"4"}},{"id":3194502,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":25877,"kind":"person","name":"Zack Debra","position":1,"cik":"0001807743","reported_name":"Zack Debra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-26T23:17:50.000Z","date":"2020-03-24","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable as it vests. 25% of the shares subject to the option vest on March 24, 2021, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date"}],"balance_after":100000,"derivative":{"exercise_price":13.44,"expiration_date":"2030-03-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-021345","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807743/000120919120021345/doc4.xml","form_type":"4"}}]}